市場調査レポート

商品コード

1619271

核医学市場規模、シェア、成長分析、診断薬別、治療薬別、用途別、エンドユーザー別、地域別 - 産業別予測、2024～2031年

Nuclear Medicine Market Size, Share, Growth Analysis, By Diagnostics (SPECT, PET), By Therapeutics (Alpha Emitters, Beta Emitters), By Application, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年12月19日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

核医学の世界市場規模は2022年に91億米ドルと評価され、予測期間（2024-2031年）のCAGRは11.8%で、2023年の101億7,000万米ドルから2031年には248億3,000万米ドルに成長する見通しです。

核医学市場は、強力な製品パイプラインと、先進的な診断・治療オプションへのアクセスを強化することを目的とした政府の支援イニシアティブによって成長を遂げています。この分野は、放射性医薬品を利用して臓器の機能や構造を評価するという複数の分野を組み合わせたもので、甲状腺がんなどの疾患の早期発見に極めて重要です。ベタルチン、オンブルタマブ、イットリウム-90マイクロスフェアなどの主要製品は現在臨床試験中です。COVID-19パンデミックによってもたらされた課題にもかかわらず、重要な医薬品を供給するために、必要不可欠なサービスに分類される原子炉は運転を継続しました。米国がん協会は、前立腺がんの罹患率の高さと、転移症例に対するPluvictoの最近のFDA承認によって証明されるように、核医学の緊急性を強調しており、この医療分野の重要性が高まっていることを強調しています。

北米
- 米国
- カナダ
欧州
- 英国
- ドイツ
- スペイン
- フランス
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021-2023）

主要企業プロファイル

GE Healthcare
Curium Pharma
Novartis
Cardinal Health
Lantheus Medical Imaging
Bracco Imaging S.P.A
Jubilant Life Sciences Ltd
Nordion（Canada）, Inc.
Siemens Healthineers
Bayer AG
Eckert & Ziegler
Telix Pharmaceuticals
NorthStar Medical Radioisotopes, LLC
Shine Medical Technologies
Isotopia Molecular Imaging Ltd.
Institute of Isotopes Co., Ltd.
Mediso Ltd.
NTP Radioisotopes SOC Ltd.
ITM Isotopen Technologien Munchen AG
Radiopharm Theranostics

結論と推奨事項

Product Code: SQMIG35I2285

Global Nuclear Medicine Market size was valued at USD 9.1 billion in 2022 and is poised to grow from USD 10.17 billion in 2023 to USD 24.83 billion by 2031, growing at a CAGR of 11.8% during the forecast period (2024-2031).

The nuclear medicine market is experiencing growth, driven by a strong product pipeline and supportive government initiatives aimed at enhancing accessibility to advanced diagnostic and therapeutic options. This field combines multiple disciplines, utilizing radiopharmaceuticals to assess organ function and structure, crucial for early disease detection such as thyroid cancer. Key products, including betalutin, omburtamab, and yttrium-90 microspheres, are currently in clinical trials. Despite the challenges posed by the COVID-19 pandemic, nuclear reactors, classified as essential services, continued operations to provide critical medicines. The American Cancer Society highlights the urgency of nuclear medicine, as evidenced by the significant incidence of prostate cancer and the recent FDA approval of Pluvicto for metastatic cases, underscoring the growing importance of this medical specialty.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nuclear Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nuclear Medicine Market Segmental Analysis

Global Nuclear Medicine Market is segmented by diagnostics, therapeutics, application, end user and region. Based on diagnostics, the market is segmented into SPECT (single photon emission computed tomography) (technetium-99m, thallium-201, iodine-123, others) and PET (positron emission tomography) (fluorine-18, rubidium-82, others). Based on therapeutics, the market is segmented into alpha emitters (radium-223, actinium-225), beta emitters (iodine-131, yttrium-90, lutetium-177) and brachytherapy isotopes (iodine-125, palladium-103, cesium-131). Based on application, the market is segmented into oncology (thyroid cancer, bone metastasis, lymphoma), cardiology (myocardial perfusion imaging, ventricular function imaging), neurology (brain imaging, alzheimer's disease) and others (gastroenterology, nephrology). Based on end user, the market is segmented into hospitals, diagnostic centers and research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nuclear Medicine Market

The Global Nuclear Medicine market is significantly driven by the increasing incidence and prevalence of cancer and cardiovascular disease (CVD). The World Health Organization reported that cancer was the leading cause of death in 2020, resulting in nearly 10 million fatalities, with projections indicating that 19.3 million new cancer cases will be diagnosed annually by 2025. Furthermore, in 2019, CVD was responsible for 17.9 million deaths, making up 32% of global mortality, and this figure is anticipated to climb to 23.3 million by 2030. The critical role of nuclear medicine in early diagnosis and treatment of these diseases is poised to propel market growth as demand for effective medical interventions rises.

Restraints in the Global Nuclear Medicine Market

The global nuclear medicine market faces several constraints, primarily due to the rising adoption of alternative diagnostic methods for various illnesses. While nuclear medicine techniques like PET scans are commonly used for cancer detection and cardiovascular imaging, technologies such as MRI and CT scans are increasingly favored, especially in developing countries. These alternatives are often more cost-effective, leading to greater utilization as they benefit from supportive reimbursement policies. Consequently, the shift towards these imaging modalities is likely to hinder the growth of the nuclear medicine market in the coming years, as healthcare providers opt for these less expensive diagnostic options.

Market Trends of the Global Nuclear Medicine Market

The global nuclear medicine market is witnessing a significant upward trend, driven by ongoing advancements in nuclear medicine therapies. Companies are increasingly focused on developing innovative therapies that showcase superior clinical efficacy compared to traditional treatment options, particularly in oncology and other high-burden diseases. This surge in demand is bolstered by regulatory endorsements, such as the US FDA's approval for Curium's Phase-III trial of lutetium Lu 177 PSMA I&T, a promising radiopharmaceutical targeting prostate cancer. Additionally, the emergence of new therapeutic agents by various market players is further stimulating growth, reflecting a robust pipeline geared toward addressing diverse medical conditions and enhancing patient care.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Patent Analysis
Case Studies

Global Nuclear Medicine Market Size by Diagnostics & CAGR (2024-2031)

Market Overview
SPECT (Single Photon Emission Computed Tomography)
- Technetium-99m
- Thallium-201
- Iodine-123
- Others
PET (Positron Emission Tomography)
- Fluorine-18
- Rubidium-82
- Others

Global Nuclear Medicine Market Size by Therapeutics & CAGR (2024-2031)

Market Overview
Alpha Emitters
- Radium-223
- Actinium-225
Beta Emitters
- Iodine-131
- Yttrium-90
- Lutetium-177
Brachytherapy Isotopes
- Iodine-125
- Palladium-103
- Cesium-131

Global Nuclear Medicine Market Size by Applications & CAGR (2024-2031)

Market Overview
Oncology
- Thyroid Cancer
- Bone Metastasis
- Lymphoma
Cardiology
- Myocardial Perfusion Imaging
- Ventricular Function Imaging
Neurology
- Brain Imaging
- Alzheimer's Disease
Others
- Gastroenterology
- Nephrology

Global Nuclear Medicine Market Size by End User & CAGR (2024-2031)

Market Overview
Hospitals
Diagnostic Centers
Research Institutes

Global Nuclear Medicine Market Size & CAGR (2024-2031)

North America, (Diagnostics, Therapeutics, Applications, End User)
- US
- Canada
Europe, (Diagnostics, Therapeutics, Applications, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Diagnostics, Therapeutics, Applications, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Diagnostics, Therapeutics, Applications, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Diagnostics, Therapeutics, Applications, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curium Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lantheus Medical Imaging
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bracco Imaging S.P.A
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Life Sciences Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nordion (Canada), Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eckert & Ziegler
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Telix Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NorthStar Medical Radioisotopes, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shine Medical Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Isotopia Molecular Imaging Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Institute of Isotopes Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mediso Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NTP Radioisotopes SOC Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ITM Isotopen Technologien Munchen AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Radiopharm Theranostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

核医学市場規模、シェア、成長分析、診断薬別、治療薬別、用途別、エンドユーザー別、地域別 - 産業別予測、2024～2031年

Nuclear Medicine Market Size, Share, Growth Analysis, By Diagnostics (SPECT, PET), By Therapeutics (Alpha Emitters, Beta Emitters), By Application, By End User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

核医学市場規模：診断別

核医学市場規模：治療法別

核医学市場規模：用途別

核医学市場規模：エンドユーザー別

核医学市場規模：地域別